Skip to main content
. 2002 Jan 21;2002(1):CD003530. doi: 10.1002/14651858.CD003530

Micheletto 1997.

Methods Setting: Italy, hospital outpatient clinic
 Length of intervention period: 8 weeks
 Randomisation: yes, method not stated
 Allocation concealment: unclear
 Design: parallel group
 Masking: unclear
 Excluded: not stated
 Withdrawals: not stated
 Baseline characteristics: no details
 Jadad score: 1
Participants 32 adults
 Age range: not stated
 Inclusion criteria:
 Adult patients with stable asthma receiving inhaled BDP 1000 mcg/day
 No other details
 Exclusion criteria:
 Not stated
Interventions BDP: 200 mcg 4xdaily (800 mcg/day) via Pulvinal DPI
BUD: 200 mcg 4xdaily (800 mcg/day) via Turbuhaler DPI
Outcomes FEV1
 FVC
 Clinic PEFR
 FEF 25‐75
 Morning PEFR
 Evening PEFR
 Daily beta2 agonist use
 Serum ECP
 Morning serum cortisol
Notes Study in abstract form only. 
 No reply from trial sponsors to clarify details of randomisation procedure, further inclusion/exclusion criteria, patient withdrawals or data for outcomes.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B ‐ Unclear